R. Varaldo

发表

Leukaemia relapse after allogeneic transplants for acute myeloid leukaemia: predictive role of WT1 expression

A. Ibatici, N. Colombo, A. Signori, 2013, British journal of haematology.

Adding low‐dose gemtuzumab ozogamicin to fludarabine, Ara‐C and idarubicin (MY‐FLAI) may improve disease‐free and overall survival in elderly patients with non‐M3 acute myeloid leukaemia: results of a prospective, pilot, multi‐centre trial and comparison with a historical cohort of patients

M. Gobbi, A. Bacigalupo, M. Miglino, 2007, British journal of haematology.

Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody—Begelomab

P. Chiusolo, A. Risitano, F. Locatelli, 2020, Bone Marrow Transplantation.

Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells

N. Colombo, Genny Del Zotto, S. Candiani, 2021, Frontiers in Immunology.

Molecular analysis of the Imatinib-induced complete cytogenetic response in chronic myelogenous leukemia

M. Gobbi, A. Ibatici, N. Colombo, 2006, Leukemia & lymphoma.

Malignant Lymphomas Molecular analysis of patients with relapsed or refractory intermediate-high grade non-Hodgkin’s lymphoma with bone marrow infiltration undergoing peripheral blood progenitor cell transplantation

M. Gobbi, L. Canepa, M. Miglino, 2001 .

Epidemiology of viral respiratory tract infections in an outpatient haematology facility

F. Ansaldi, C. Viscoli, A. Orsi, 2013, Annals of Hematology.

Good tolerability of high dose colistin-based therapy in patients with haematological malignancies

M. Gobbi, C. Viscoli, F. Gualandi, 2017, Infection.

De-Escalation and Discontinuation of Empirical Antibiotic Treatment in a Cohort of Allogeneic Hematopoietic Stem Cell Transplantation Recipients during the Pre-Engraftment Period.

C. Viscoli, A. Bacigalupo, E. Angelucci, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant

P. Chiusolo, A. Bacigalupo, E. Angelucci, 2022, Blood Cancer Journal.

Improved Outcome of Alternative Donor Transplantations in Patients with Myelofibrosis: From Unrelated to Haploidentical Family Donors.

G. Barosi, T. Lamparelli, A. Bacigalupo, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Unmanipulated haploidentical BMT following non-myeloablative conditioning and post-transplantation CY for advanced Hodgkin’s lymphoma

L. Giordano, A. Ibatici, L. Castagna, 2014, Bone Marrow Transplantation.

Physicians Poster Sessions

R. Bouabdallah, D. Blaise, L. Giordano, 2016, Bone Marrow Transplantation.

Rituximab treatment for Epstein-Barr virus DNAemia after alternative-donor hematopoietic stem cell transplantation.

A. Ibatici, F. Frassoni, T. Lamparelli, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Fludarabine, ARA-C, idarubicin and G-CSF (FLAG-Ida), high dose ARA-C and early stem cell transplant. A feasable and effective therapeutic strategy for de novo AML patients.

M. Gobbi, A. Bacigalupo, L. Canepa, 2002, Journal of experimental & clinical cancer research : CR.

Monitoring molecular response by BCR-ABL, JH and WT-1 in Ph+ all treated with imatinib containing regimen: preliminary report of two cases.

M. Gobbi, N. Colombo, M. Miglino, 2006, Journal of experimental & clinical cancer research : CR.

Wilms Tumor 1 Expression and Pre-emptive Immunotherapy in Patients with Acute Myeloid Leukemia Undergoing an Allogeneic Hemopoietic Stem Cell Transplantation.

A. Ibatici, N. Colombo, T. Lamparelli, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HSCT for acute myeloid leukaemia in adults

F. Frassoni, R. Varaldo, 2008 .

Hepatitis E Virus Infection in an Italian Cohort of Hematopoietic Stem Cell Transplantation Recipients: Seroprevalence and Infection

C. Viscoli, E. Angelucci, A. Raiola, 2020 .

Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning.

T. Lamparelli, A. Bacigalupo, M. Miglino, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Seventeen years of experience with ATRA-based therapy for acute promyelocytic leukaemia: long-term follow-up of patients treated at S. Martino Hospital, Genoa.

M. Gobbi, N. Colombo, M. Miglino, 2009, Oncology reports.

Haploidentical hemopoietic cell transplantation for myelofibrosis, in ruxolitinib era.

I. Schiavetti, A. Bacigalupo, E. Angelucci, 2022, Transplantation and cellular therapy.

Unmanipulated haploidentical bone marrow transplantation and post-transplant cyclophosphamide for hematologic malignanices following a myeloablative conditioning: an update

N. Colombo, T. Lamparelli, A. Bacigalupo, 2015, Bone Marrow Transplantation.

CD34 selected cells for the treatment of poor graft function after allogeneic stem cell transplantation.

T. Lamparelli, A. Bacigalupo, F. Gualandi, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CMV infection after transplant from cord blood compared to other alternative donors: the importance of donor-negative CMV serostatus.

P. Bruzzi, C. Viscoli, F. Frassoni, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome.

C. Viscoli, A. Signori, A. Bacigalupo, 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts.

M. Gobbi, A. Ibatici, A. Signori, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Rapid Immune Reconstitution Following Unmanipulated Haploidentical BMT with Post-Transplant High Dose Cyclophosphamide

F. Frassoni, A. Bacigalupo, F. Gualandi, 2011 .

The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantation

P. Chiusolo, A. Signori, T. Lamparelli, 2021, Blood advances.

The intra-bone marrow injection of cord blood cells extends the possibility of transplantation to the majority of patients with malignant hematopoietic diseases.

G. Sambuceti, F. Frassoni, A. Bacigalupo, 2010, Best practice & research. Clinical haematology.

Visceral leishmaniasis in hematopoietic cell transplantation: Case report and review of the literature.

M. Gramiccia, L. Gradoni, C. Viscoli, 2018, Journal of Infection and Chemotherapy.

Treatment of Philadelphia-Positive Chronic Myeloid Leukemia with Imatinib: Importance of a Stable Molecular Response

M. Baccarani, G. Rosti, G. Martinelli, 2009, Clinical Cancer Research.

Second haploidentical stem cell transplantation for primary graft failure

P. Chiusolo, A. Bacigalupo, E. Angelucci, 2020, Bone Marrow Transplantation.

Impact of HLA Disparity in Haploidentical Bone Marrow Transplantation Followed by High-Dose Cyclophosphamide.

A. Risitano, A. Ibatici, A. Signori, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse

M. Gobbi, F. Destefano, A. Bacigalupo, 2002, Bone Marrow Transplantation.

Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor.

C. Viscoli, A. Signori, A. Bacigalupo, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Treatment of Patients with Steroid Refractory Acute Graft Vs Host Disease (SR-GvHD): A Matched Paired Analysis of Anti-CD26 (Begelomab) Compared to Other Treatment

H. Deeg, A. Bacigalupo, F. Gualandi, 2016 .

The new small tyrosine-kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programs.

M. Gobbi, A. Neri, B. Schwartz, 2019, Haematologica.

The new small molecule tyrosine-kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programs

M. Gobbi, A. Neri, B. Schwartz, 2019 .

Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-up

M. Baccarani, G. Rosti, G. Martinelli, 2008, Haematologica.

Thalidomide in agnogenic and secondary myelofibrosis

M. Gobbi, L. Canepa, M. Miglino, 2001, British journal of haematology.

Haploidentical Transplants with Post-Transplant Cyclophosphamide for Relapsed or Refractory Hodgkin Lymphoma: The Role of Comorbidity Index and Pretransplant Positron Emission Tomography.

M. Gobbi, A. Ibatici, S. Morbelli, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The addition of radiotherapy to chemotherapy does not improve outcome of early stage Hodgkin’s lymphoma patients: a retrospective long-term follow-up analysis of a regional Italian experience

M. Gobbi, L. Canepa, A. Carella, 2009, Annals of Hematology.

Quality of life and brain function following high‐dose recombinant human erythropoietin in low‐risk myelodysplastic syndromes: a preliminary report

M. Gobbi, P. Vitali, F. Nobili, 2004, European journal of haematology.

Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia

M. Gobbi, A. Bacigalupo, M. Miglino, 2014, Annals of Hematology.

DLI after haploidentical BMT with post-transplant CY

T. Lamparelli, A. Bacigalupo, F. Gualandi, 2015, Bone Marrow Transplantation.

Aggressive multiple sclerosis: a single‐centre, real‐world treatment experience with autologous haematopoietic stem cell transplantation and alemtuzumab

M. Inglese, L. Roccatagliata, A. Uccelli, 2020, European journal of neurology.

Total marrow irradiation for second allogeneic hematopoietic stem cell transplantation in patients with advanced acute leukemia.

S. Agostinelli, E. Angelucci, F. Gualandi, 2020, Transplantation and cellular therapy.

Autologous hematopoietic stem cell transplantation following alemtuzumab therapy in aggressive multiple sclerosis: A report of three cases

M. Inglese, G. Mancardi, P. Gallo, 2020, Multiple sclerosis.

Menstrual cycle resumption and female fertility after autologous hematopoietic stem cell transplantation for multiple sclerosis

M. Inglese, G. Mancardi, G. Boffa, 2021, Multiple sclerosis.

Pre-engraftment bloodstream infections after allogeneic hematopoietic cell transplantation: the impact of T-repleted transplant from haploidentical donors. Authors

Balletto, C. Viscoli, A. Bacigalupo, 2017 .

Apoptosis reprogramming triggered by splicing inhibitors sensitizes multiple myeloma cells to Venetoclax treatment

N. Munshi, M. Samur, A. Neri, 2021, Haematologica.

Post-Transplant Cyclophosphamide Following a Myeloablative Conditioning For Hematologic Malignancies Receiving An Unmanipulated Haploidentical Bone Marrow Transplant

T. Lamparelli, A. Bacigalupo, M. Miglino, 2013 .

Faculty Opinions recommendation of Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: t(8;21) and inv(16) represent different clinical outcomes.

R. Varaldo, 2009 .

HEV infection in an Italian cohort of HSCT recipients: seroprevalence and infection.

C. Viscoli, E. Angelucci, A. Raiola, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor.

C. Viscoli, A. Signori, A. Bacigalupo, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Myelofibrosis: Report of five cases treated with thalidomide

L. Canepa, R. Grasso, R. Varaldo, 2000 .

Natural Killer (NK) Alloreactivity Seems Not to Play a Role in Preventing Leukemia Relapse in Unmanipulated Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide

M. Gobbi, A. Bacigalupo, F. Gualandi, 2015 .

Total marrow irradiation for second allogeneic hematopoietic stem cell transplantation in patients with advanced acute leukemia.

E. Angelucci, A. Dominietto, A. Raiola, 2023, Transplantation and cellular therapy.

Visceral leishmaniasis in hematopoietic cell transplantation: Case report and review of the literature.

M. Gramiccia, L. Gradoni, E. Angelucci, 2018, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.